To provide support for the implementation of user fees mdufa unearned funds reclassification and refunds process automation in the near future. High level objectives are stratified using priorities as…
Ended Awarded Last action
- Contract number
- 75F40122F19014
- Awardee
-
Equinoxys Inc. UEI KB8BBLEREKL6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $403,094
Award facts
- Contract value 100% obligated
- $403,094.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541513 Computer Facilities Management Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Calverton, MD 20705, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$17,443 | |
| Original award | $420,538 |
About this award
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned IT services company. The contract, valued at $403,094.39, is a Blanket Purchase Agreement (BPA) call order under the Multiple Award Schedule (MAS) contract vehicle.
The contract is to provide support for the implementation of user fees and MDUFA (Medical Device User Fee Amendments) unearned funds reclassification and refunds process automation for the FDA. The high-level objectives are to automate the reclassification of MDUFA unearned funds and implement a refunds process. This work supports the FDA's Unified Financial Management System (UFMS) and user fee systems, including modernization, data analytics, and process automation efforts. The contract does not have a set-aside designation and is scheduled for completion on February 15, 2023.
Description
To provide support for the implementation of user fees mdufa unearned funds reclassification and refunds process automation in the near future. High level objectives are stratified using priorities as P1 and P2: 1. Automate reclass of mdufa UNE
Quick answers
Who was awarded contract 75F40122F19014?
75F40122F19014 was awarded to Equinoxys Inc. by Food and Drug Administration (Department of Health and Human Services) on May 11, 2022.
How much is contract 75F40122F19014 worth?
The government has obligated $403,094 on 75F40122F19014.
Is contract 75F40122F19014 an order under another contract?
Yes. 75F40122F19014 is a BPA call under GS35F0331V-75F40118A10047, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40122F19014 competed?
The extent of competition for 75F40122F19014 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award